Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$529K Buy
2,376
+17
+0.7% +$3.85K 0.01% 645
2026
Q1
$399K Sell
2,359
-126
-5% -$22K 0.01% 647
2025
Q4
$405K Buy
2,485
+379
+18% +$57K 0.01% 652
2025
Q3
$285K Buy
2,106
+49
+2% +$6.94K 0.01% 696
2025
Q2
$266K Sell
2,057
-612
-23% -$71.5K 0.01% 689
2025
Q1
$321K Sell
2,669
-180
-6% -$23.2K 0.01% 634
2024
Q4
$333K Buy
+2,849
New +$410K 0.01% 596

Other funds holding NUE

Cary Street Partners's NUE Position: Q2 2026 in Review

Cary Street Partners increased its Nucor (NUE) stake by 0.72% in Q2 2026, buying an estimated $3.85K and bringing the position to 2,376 shares worth $529K. The position accounts for 0.01% of the portfolio, ranked #645.

Cary Street Partners first reported a position in NUE in Q4 2024 and has held it in 7 quarters since. 508 funds tracked by Wall St. Rank hold NUE as of Q2 2026.

  • Cary Street Partners held 2,376 shares of Nucor worth $529K as of Q2 2026.
  • Cary Street Partners bought 17 Nucor shares in Q2 2026, an estimated $3.85K.
  • Nucor made up 0.01% of Cary Street Partners's portfolio in Q2 2026, its #645 holding.
  • Cary Street Partners first reported a position in Nucor in Q4 2024 and has held it in 7 quarters since.
  • 508 funds tracked by Wall St. Rank held Nucor as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.